sarpogrelate has been researched along with Hypoxia in 2 studies
sarpogrelate: structure given in first source
Hypoxia: Sub-optimal OXYGEN levels in the ambient air of living organisms.
| Excerpt | Relevance | Reference |
|---|---|---|
| "This study investigated whether sarpogrelate hydrochloride (SPG), a 5-HT2A receptor antagonist, alleviates chronic hypoxic pulmonary hypertension (CH-PH) in rats by stimulating apoptosis and inhibiting proliferation in pulmonary artery smooth muscle cells (PASMCs)." | 7.83 | The effects of the 5-HT2A receptor antagonist sarpogrelate hydrochloride on chronic hypoxic pulmonary hypertension in rats. ( Fan, FL; Geng, J; He, S; Liu, Y; Ma, Q; Meng, Y; Tian, H; Tian, HY; Zhang, D; Zhang, JB, 2016) |
| "The purpose of the present study was to determine if sarpogrelate hydrochloride (SPG), a serotonin 5HT2A receptor antagonist, prevented the development of chronic hypoxia-induced pulmonary hypertension (PH) and hypertensive pulmonary vascular remodeling." | 7.81 | Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats. ( Ma, N; Maruyama, J; Maruyama, K; Mitani, Y; Nishikawa, M; Sawada, H; Yokochi, A; Zhang, E, 2015) |
| "This study investigated whether sarpogrelate hydrochloride (SPG), a 5-HT2A receptor antagonist, alleviates chronic hypoxic pulmonary hypertension (CH-PH) in rats by stimulating apoptosis and inhibiting proliferation in pulmonary artery smooth muscle cells (PASMCs)." | 3.83 | The effects of the 5-HT2A receptor antagonist sarpogrelate hydrochloride on chronic hypoxic pulmonary hypertension in rats. ( Fan, FL; Geng, J; He, S; Liu, Y; Ma, Q; Meng, Y; Tian, H; Tian, HY; Zhang, D; Zhang, JB, 2016) |
| "The purpose of the present study was to determine if sarpogrelate hydrochloride (SPG), a serotonin 5HT2A receptor antagonist, prevented the development of chronic hypoxia-induced pulmonary hypertension (PH) and hypertensive pulmonary vascular remodeling." | 3.81 | Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats. ( Ma, N; Maruyama, J; Maruyama, K; Mitani, Y; Nishikawa, M; Sawada, H; Yokochi, A; Zhang, E, 2015) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zhang, E | 1 |
| Maruyama, J | 1 |
| Yokochi, A | 1 |
| Mitani, Y | 1 |
| Sawada, H | 1 |
| Nishikawa, M | 1 |
| Ma, N | 1 |
| Maruyama, K | 1 |
| Geng, J | 1 |
| Fan, FL | 1 |
| He, S | 1 |
| Liu, Y | 1 |
| Meng, Y | 1 |
| Tian, H | 1 |
| Zhang, D | 1 |
| Ma, Q | 1 |
| Zhang, JB | 1 |
| Tian, HY | 1 |
2 other studies available for sarpogrelate and Hypoxia
| Article | Year |
|---|---|
Sarpogrelate hydrochloride, a serotonin 5HT2A receptor antagonist, ameliorates the development of chronic hypoxic pulmonary hypertension in rats.
Topics: Animals; Hypertension, Pulmonary; Hypertrophy, Right Ventricular; Hypoxia; Lung; Male; Nitric Oxide | 2015 |
The effects of the 5-HT2A receptor antagonist sarpogrelate hydrochloride on chronic hypoxic pulmonary hypertension in rats.
Topics: Animals; Apoptosis; Cell Proliferation; Chronic Disease; Hypertension, Pulmonary; Hypoxia; Male; Myo | 2016 |